- Home
- LCNB vs PRQR Comparison
LCNB vs PRQR Comparison
Compare LCNB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LCNB | PRQR |
|---|---|---|
| Founded | 1877 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.9M | 262.5M |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LCNB | PRQR |
|---|---|---|
| Price | $19.77 | $1.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $20.83 | $7.78 |
| AVG Volume (30 Days) | 20.4K | ★ 968.3K |
| Earning Date | 10-15-2026 | 11-13-2026 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | ★ 68.04 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $6,445,000.00 | N/A |
| Revenue This Year | $11.08 | $8.25 |
| Revenue Next Year | $0.51 | N/A |
| P/E Ratio | $23.62 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.83 | $1.20 |
| 52 Week High | $21.32 | $2.81 |
Technical Indicators
Market Signals| Indicator | LCNB | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 60.98 | 39.53 |
| Support Level | $18.44 | N/A |
| Resistance Level | $20.29 | $1.99 |
| Average True Range (ATR) | 0.51 | 0.10 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 90.57 | 39.29 |
Price Performance
Historical ComparisonAbout LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.